DR REDDYS LABORATORIES LTD
Business
Dr. Reddy's Laboratories Limited is an integrated global pharmaceutical company developing, manufacturing, and marketing generic pharmaceuticals, active pharmaceutical ingredients, biosimilars, and consumer healthcare products. The company operates three reportable segments: Global Generics (generics, biosimilars, and OTC products across regulated and emerging markets); Pharmaceutical Services and Active Ingredients (APIs, intermediates, and contract manufacturing services); and Others (early-stage biotech and proprietary products). Core markets include the United States, India, Russia, Europe, and emerging markets.
Summary from 20-F filed 2026-05-29
Financials
Latest annual snapshot (FY2026, period end 2026-03-31). Full statement history unavailable for this entity.
| Revenue | — |
| Net income | $452.00M |
| Total assets | $6.17B |
| Total liabilities | $2.12B |
| Stockholders' equity | — |
| Operating cash flow | — |
Filings
Material Events
Insiders
Institutional Holders
Frequently asked questions
What is DR REDDYS LABORATORIES LTD's CIK number?
DR REDDYS LABORATORIES LTD's SEC CIK number is 0001135951 (1135951). The CIK (Central Index Key) is the permanent identifier the SEC assigns to every EDGAR filer — unlike a ticker symbol, it never changes.
Where can I find DR REDDYS LABORATORIES LTD's SEC filings?
All of DR REDDYS LABORATORIES LTD's EDGAR filings — 10-K annual reports, 10-Q quarterly reports, 8-K material events, and insider transactions — are listed on this page, sourced live from SEC EDGAR.